Replies to post #191288 on Biotech Values

[biomaven0]

>>aria

With a modest course change under new management I think the company would have a good future. Briga is the key asset, although their new magic and secret TKI is going to be of interest as well. (I have a strong suspicion what target they are going after).

Biggest long term risk to my mind is that combos with immune oncology start providing cures.

[ilpapa]

Is ARIA really worth the bother at the current valuation?

Certainly on the ARIAD board, teeming with bulls. $15 bucks at least, as you know since you follow that board.

I own some with a good gain. Enough to hurt if Briga bombs, tho not as much as when Pona did.